CytoSorb purification in critically ill SARS-CoV-2 patients.

Marina PieriEvgeny FominskiyPasquale NardelliMatteo A BonizzoniAnna Mara Scandroglio

Published in: The International journal of artificial organs (2021)

CytoSorb treatment was effective in improving several laboratory parameters and inflammation in our experience and no treatment-related adverse effects were recorded. In the light of the unique pathophysiology of SARS-CoV-2 infection, CytoSorb treatment is extremely promising, since it might both reduce inflammation and activation of coagulation.

Keyphrases

sars cov
oxidative stress
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
respiratory syndrome coronavirus
drug induced